Back to Search
Start Over
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
- Source :
- JAMA Network Open, JAMA Network Open, 2021, 4 (11), pp.e2136030. ⟨10.1001/jamanetworkopen.2021.36030⟩
- Publication Year :
- 2021
- Publisher :
- American Medical Association (AMA), 2021.
-
Abstract
- International audience; This case series study assesses whether a fourth dose of a SARS-CoV-2 messenger RNA (mRNA)–based vaccine is associated with improved anti–SARS-CoV-2 antibody response in solid organ transplant recipients in France.
- Subjects :
- Adult
Male
MESH: COVID-19 / immunology
2019-20 coronavirus outbreak
COVID-19 Vaccines
MESH: Antibodies, Viral / immunology
Coronavirus disease 2019 (COVID-19)
viruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MESH: SARS-CoV-2 / immunology
MESH: Transplant Recipients
Antibodies, Viral
MESH: COVID-19 Vaccines / therapeutic use
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Research Letter
Humans
Medicine
skin and connective tissue diseases
MESH: Antibodies, Viral / blood
Messenger RNA
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
MESH: Middle Aged
biology
SARS-CoV-2
business.industry
Research
fungi
COVID-19
Organ Transplantation
General Medicine
Middle Aged
Virology
Transplant Recipients
respiratory tract diseases
body regions
Online Only
Infectious Diseases
MESH: Organ Transplantation
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
biology.protein
Female
Antibody
Solid organ transplantation
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Subjects
Details
- ISSN :
- 25743805
- Volume :
- 4
- Database :
- OpenAIRE
- Journal :
- JAMA Network Open
- Accession number :
- edsair.doi.dedup.....a854787658cb7c8ede04f7653d238c72
- Full Text :
- https://doi.org/10.1001/jamanetworkopen.2021.36030